3G Biotech (China) Company
3G Biotech (China) Company focus its business in pharmacogenomics to develop diagnostic reagents for clinical practice and to offer services of companion diagnostic gene-test for personalized medicine in China.
Our vision is to be the best partner of pharmaceutical companies for clinical trial and commercialization, to be the best service-supplier of hospitals and doctors in the region of personalized medicine and companion diagnostics in China.
Based on the trend of 4P medicine model combined with actual Chinese market situation, with the cooperation of strategic partner – Xiang Ya Medical University, 3G Biotech founded its own R&D center to develop molecular diagnostic reagents for companion diagnostics, and produce those reagents in its own factory.
3G Biotech offers a service package for hospitals and forms a clinical network:
Building joint molecular diagnostic labs within Chinese big hospitals, investing PCR and Pyrosequencing equipments, setting up SOP, offering reagents and technicians to offer clinical gene-test for personalized medicine, especially in the region of cancer, cardiovascular disease, immunoregulation and hepatitis.
Our promotion team co-operate with pharmacists, clinical lab doctors and pathologists of these hospitals to educate clinical physicians – mini workshop, CME, etc, to offer the explanation of test result and suggestion for personalized therapy.
Developing and producing molecular diagnostic reagents, 25 of joint labs within hospitals (another 15 under construction in 2013), 3G Biotech has the capability to be the best partner for pharmaceutical companies for companion diagnostics.